Beurel, Eléonore <br/><br/>
Glycogen synthase kinase-3 inhibitors augment TRAIL-induced apoptotic death in human hepatoma cells.  [electronic resource] 

 -  Biochemical pharmacology  Jan 2009 
 - 54-65 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1873-2968 
<br/><br/><label>Standard No.: </label>10.1016/j.bcp.2008.09.026  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aminophenols--pharmacology<br/>Apoptosis--drug effects<br/>Carcinoma, Hepatocellular--drug therapy<br/>Cell Line, Tumor<br/>Cells, Cultured<br/>Drug Synergism<br/>Glycogen Synthase Kinase 3--antagonists & inhibitors<br/>Humans<br/>Lithium--pharmacology<br/>Liver Neoplasms--drug therapy<br/>Maleimides--pharmacology<br/>Protein Kinase Inhibitors--pharmacology<br/>TNF-Related Apoptosis-Inducing Ligand--physiology<br/>Tumor Cells, Cultured